These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2767708)

  • 1. Reversible injury of cultured rat oligodendrocytes by complement.
    Scolding NJ; Houston WA; Morgan BP; Campbell AK; Compston DA
    Immunology; 1989 Aug; 67(4):441-6. PubMed ID: 2767708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.
    Scolding NJ; Morgan BP; Houston A; Campbell AK; Linington C; Compston DA
    J Neurol Sci; 1989 Feb; 89(2-3):289-300. PubMed ID: 2926453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.
    Scolding NJ; Morgan BP; Houston WA; Linington C; Campbell AK; Compston DA
    Nature; 1989 Jun; 339(6226):620-2. PubMed ID: 2733792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.
    Piddlesden SJ; Morgan BP
    J Neuroimmunol; 1993; 48(2):169-75. PubMed ID: 7693753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement mediated serum cytotoxicity against oligodendrocytes: a comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage.
    Scolding NJ; Morgan BP; Campbell AK; Compston DA
    J Neurol Sci; 1990 Jul; 97(2-3):155-62. PubMed ID: 2205708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of kainate receptors sensitizes oligodendrocytes to complement attack.
    Alberdi E; Sánchez-Gómez MV; Torre I; Domercq M; Pérez-Samartín A; Pérez-Cerdá F; Matute C
    J Neurosci; 2006 Mar; 26(12):3220-8. PubMed ID: 16554473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis.
    Cid C; Alvarez-Cermeño JC; Salinas M; Alcázar A
    J Neurochem; 2005 Oct; 95(2):349-60. PubMed ID: 16135098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocyte susceptibility to injury by T-cell perforin.
    Scolding NJ; Jones J; Compston DA; Morgan BP
    Immunology; 1990 May; 70(1):6-10. PubMed ID: 2354862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation.
    Scolding NJ; Frith S; Linington C; Morgan BP; Campbell AK; Compston DA
    J Neuroimmunol; 1989 May; 22(3):169-76. PubMed ID: 2649509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal complement complexes.
    Shirazi Y; Imagawa DK; Shin ML
    J Neurochem; 1987 Jan; 48(1):271-8. PubMed ID: 3025367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies.
    Scolding NJ; Compston DA
    Immunology; 1991 Jan; 72(1):127-32. PubMed ID: 1997396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Ca2+ changes in individual oligodendrocytes attacked by T-cell perforin.
    Jones J; Frith S; Piddlesden S; Morgan BP; Compston DA; Campbell AK; Hallett MB
    Immunology; 1991 Dec; 74(4):572-7. PubMed ID: 1783417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].
    Taranova NP; Kirchik OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls.
    Hirayama M; Lisak RP; Silberberg DH
    Neurology; 1986 Feb; 36(2):276-8. PubMed ID: 3945400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demyelination in brain cell aggregate cultures, induced by a monoclonal antibody against the myelin/oligodendrocyte glycoprotein (MOG).
    Honegger P; Matthieu JM; Lassmann H
    Schweiz Arch Neurol Psychiatr (1985); 1989; 140(1):10-3. PubMed ID: 2467359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cytotoxicity to oligodendrocytes in multiple sclerosis and controls: assessment by 51Cr release assay.
    Suzumura A; Lisak RP; Silberberg DH
    J Neuroimmunol; 1986 Apr; 11(2):137-47. PubMed ID: 3949965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59.
    Wing MG; Zajicek J; Seilly DJ; Compston DA; Lachmann PJ
    Immunology; 1992 May; 76(1):140-5. PubMed ID: 1378423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of oligodendrocyte interaction with normal human serum--defining the role of complement.
    Zajicek J; Wing MG; Lachmann PJ; Compston DA
    J Neurol Sci; 1992 Mar; 108(1):65-72. PubMed ID: 1624954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg").
    Stangel M; Compston A; Scolding NJ
    J Neuroimmunol; 2000 Mar; 103(2):195-201. PubMed ID: 10696915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human alpha-fetoprotein-rich fraction inhibits galactocerebroside antibody-mediated lysis of oligodendrocytes in vitro.
    Lubetzki-Korn I; Hirayama M; Silberberg DH; Schreiber AD; Eccleston PA; Pleasure D; Brenner T; Abramsky O
    Ann Neurol; 1984 Feb; 15(2):171-80. PubMed ID: 6200057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.